Compare 10X Genomics Inc (TXG) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Zoetis Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Zoetis Inc is far larger — about 5.8× 10X Genomics Inc's market cap, and Zoetis Inc pays a 2.78% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | ZTS | |
|---|---|---|
Market Cap | $5.48B | $31.95B |
Sector | Health | Health |
52-Week High | $45.80 | $156.76 |
52-Week Low | $11.34 | $71.91 |
Enterprise Value | $5.02B | $39.24B |
Dividend Yield | — | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
